How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?

Published:2016 Issue:Suppl 1 Volume:57 Page:S44
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Yun Seok Joong¹,Kim Seon-Kyu²³,Kim Wun-Jae¹

Affiliation:

1. Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.

2. Medical Genomics Research Center, Research Institute of Bioscience and Biotechnology, Daejeon, Korea.

3. Korean Bioinformation Center, Research Institute of Bioscience and Biotechnology, Daejeon, Korea.

Funder

Chungbuk National University

Publisher

The Korean Urological Association

Subject

Urology

Link

http://synapse.koreamed.org/pdf/10.4111/icu.2016.57.S1.S44

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer;Asia-Pacific Journal of Clinical Oncology;2024-04-04

2. COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype;Investigative and Clinical Urology;2024

3. Effects of intravenous chemotherapy after TURBT for high-risk nonmuscle invasive bladder cancer: results of a retrospective study;Journal of Cancer Research and Clinical Oncology;2023-08-04

4. Novel potential urinary biomarkers for effective diagnosis and prognostic evaluation of high-grade bladder cancer;Translational Cancer Research;2023-08

5. A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy;International Journal of Molecular Sciences;2021-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3